Bringing the fundamentals into focus…

How Johnson & Johnson stacks up

JNJ · against 5 other Healthcare companies of similar size

Overall

59/ 100

Above the middle of the pack.

Ranked #3 of 6 · scores higher than 60% of peers

Bars: peers in each 10-point band of the overall score

2 peers with an overall score of 50–59, including JNJ · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#3 of 6Score 60 / 100 · beats 60%Growth#4 of 6Score 48 / 100 · beats 40%Profitability#3 of 6Score 91 / 100 · beats 60%Risk#1 of 6Moderate relative risk · safety 38 · beats 100%

Ranking by overall score

Top 5 and the companies ranked around JNJ

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Eli Lilly and CompanyLLY · US-listed	1.06T USD	63	50	91	97	2 / 2
2	Roche Holding AGRO.SW · Europe	293.8B CHF (≈$337.9B)	61	73	49	97	2 / 2
3	Johnson & JohnsonJNJ · US-listed	622.8B USD	59	60	48	91	1 / 2
4	AbbVie Inc.ABBV · US-listed	479.5B USD	53	49	66	87	2 / 2
5	UnitedHealth Group IncorporatedUNH · US-listed	337.5B USD	48	67	38	61	2 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score